Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.
≥98% PurityIn-House HPLC & MS Tested
BioregulatorsSKU: CP-OV20
Ovagen 20mg
≥99% PurityHPLC & MS verified
€32.99Out of Stock
Delivers to EU in 7-10 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade Ovagen. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
📦
MADE TO ORDER — Expected delivery: ~3 weeks
Synthesized after your order is placed. We'll email you tracking details when it ships.
Currently Unavailable34 researchers waiting
This product is being restocked
We're working with our supplier to restock this item. Sign up below to be the first to know, or save it to your wishlist.
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
When This Product May Not Suit Your Research
- ⚠If your research requires GMP-grade material for clinical applications — research-grade peptides are not intended for clinical use.
- ⚠If your lab lacks proper cold storage (-20°C freezer) — this peptide's stability may be compromised at higher temperatures.
- ⚠If your study protocol requires FDA-approved reference standards — contact USP or a certified reference material provider.
Purity HPLC
99.3% average HPLC purity, verified by independent third-party testing
Third-Party Tested
Janoshik report published when available
Fast Shipping
24h dispatch, EU-wide shipping from €4.99
Third-Party Tested
Independent lab verification for every batch
Last reviewed: 2026-04-05
About Ovagen 20mg
Ovagen is a tripeptide (Lys-Glu-Asp / KED) from the Khavinson series targeting ovarian tissue and female reproductive biology. The research focus is ovarian follicle homeostasis, age-related ovarian function decline, and the gene expression changes associated with reproductive aging. Ovarian aging involves progressive follicle depletion and altered granulosa cell function — the transcriptional programs governing folliculogenesis change significantly over time, and this change precedes the systemic hormonal shifts of menopause by years.
The Khavinson approach to ovarian tissue: short peptide modulation of gene expression in granulosa cells and ovarian tissue to study or potentially influence age-related changes. Published Khavinson data on Ovagen examines granulosa cell gene expression, ovarian morphology in aging models, and follicle reserve indicators in preclinical studies. Note that Ovagen shares its KED sequence with Vesugen (vascular endothelium target) — the same sequence, different tissue context, consistent with the Khavinson tissue-distribution hypothesis.
Specifications
| Sequence | Lys-Glu-Asp (KED) |
|---|---|
| Molecular Weight | ~375 Da (tripeptide) |
| Purity | 99.3% avg by HPLC |
| Form | Lyophilized powder |
| Sizes | 20mg |
Storage: Lyophilized: −20°C, away from light. Once reconstituted: 2–8°C, use within 4 weeks.
Quality: HPLC purity analysis, mass spec identity confirmation, endotoxin testing on every batch. COA ships with every order. EU-based QC under CERTALAB S.R.L.
Frequently Asked Questions
What does reproductive aging research with Ovagen examine?
Published Khavinson work examines granulosa cell gene expression, ovarian morphology changes in aging models, and follicle reserve indicators. The transcriptional programs governing folliculogenesis — including FSH receptor expression, steroidogenic enzyme genes, and anti-Müllerian hormone production — are the proposed modulation targets. Ovarian aging often precedes visible systemic hormonal changes, making it an important tissue for studying reproductive senescence.
Why does Ovagen share its sequence with Vesugen if they target different tissues?
The Khavinson framework holds that tissue specificity derives from distribution following administration rather than from the peptide sequence alone. The KED tripeptide (Lys-Glu-Asp) reaching ovarian granulosa cells is proposed to interact with different available promoter sites than the same sequence reaching vascular endothelial cells. Researchers can test this directly by comparing Ovagen and Vesugen effects in the same model to understand how much tissue context shapes the outcome of identical sequences.
For research purposes only. Not for human consumption.
Specification Summary
Purity99.3% avg
FormLyophilized Powder
Storage-20\u00B0C
Researcher Confidence
Why researchers choose CertaPeptides
Who actually tests this?
Every batch is independently verified by Janoshik Analytical (100,000+ verifications/month), Eurofins Scientific, and Analytical Sciences International. We publish every Certificate of Analysis.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI RO54451735, VAT-registered. SameDay for Romania, FanCourier for Central/Eastern EU, TCE Worldwide for the rest. 3–7 business days EU-wide.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →Product Information
This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
Frequently Asked
Research Library
Related Research Articles
Based on category & popularity
Researchers Also Studied
20mgSAME FIELDBioregulators
Vesugen 20mg
Research-grade Vesugen. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99
20mgSAME FIELDBioregulators
Crystagen 20mg
Research-grade Crystagen. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99
20mgSAME FIELDBioregulators
Chonluten 20mg
Research-grade Chonluten. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99
20mgSAME FIELDBioregulators
Cartalax 20mg
Research-grade Cartalax. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99